Aviv Scientific

Cognitive and Functional Decline Treatment Solutions

Health Tech & Life Sciences
Active
Series B Bnei Brak Founded 2017
Total raised
$62.0M
Last: Series B 2021-09
Stage
Series B
Founded
2017
Headcount
23
HQ
Bnei Brak
Sector
Health Tech & Life Sciences

About

Aviv Scientific specializes in the treatment of age-related cognitive and functional decline, with a focus on novel applications of hyperbaric medicine to maximize human performance. The company aims to improve the aging process by increasing cognitive and physical performance in healthy aging adults. Based on an exclusive global partnership with the worlds largest hyperbaric medicine and research facility, the Sagol Center at Shamir Medical Center in Israel, Aviv Scientific is rolling out a global network of medical clinics focused on the enhancement of cognitive and physical performance with hyperbaric medicine and related technologies at its core. The Aviv Medical Program combines the unique protocols of hyperbaric oxygen therapy (HBOT) with a proprietary personalized program of cognitive and physical training. More than 1,000 people worldwide have already been treated in accordance with Avivs progressive 12-week program, currently offered at Aviv clinics in Florida and Dubai. Aviv Scientific has successfully combined personalized medicine, advanced technologies, big data, and analytics with its specialized operational skills to build a worldwide network of medical clinics.

Funding history · 2 rounds · $62.0M total

2021-09
Series B $40.0M
2021-06
Undisclosed $22.0M

Company Intelligence Q&A

Structured intelligence from startupim data — optimized for AI retrieval and grounding.

When was Aviv Scientific founded?
Aviv Scientific was founded in July 2017.
What is Aviv Scientific's primary focus?
Aviv Scientific specializes in treating age-related cognitive and functional decline, utilizing novel applications of hyperbaric medicine to enhance human performance.
How much funding has Aviv Scientific raised in total?
Aviv Scientific has raised a total of $62,000,000 across multiple funding rounds. For a full financing history, refer to startupim.
Which investors participated in Aviv Scientific's Series B round?
Aviv Scientific's Series B round in September 2021 was led by Deep Insight, with participation from Danel Group.
Where are Aviv Scientific's clinics currently located?
Aviv Scientific operates clinics in Florida, USA, and Dubai, United Arab Emirates.
What is the basis of Aviv Scientific's medical program?
The Aviv Medical Program combines unique hyperbaric oxygen therapy (HBOT) protocols with a personalized program of cognitive and physical training.
How many people have been treated with Aviv Scientific's program?
More than 1,000 people worldwide have been treated with Aviv Scientific's 12-week program.
What is Aviv Scientific's global partnership related to hyperbaric medicine?
Aviv Scientific has an exclusive global partnership with the Sagol Center at Shamir Medical Center in Israel, which is the world's largest hyperbaric medicine and research facility.
What was a key finding highlighted by Aviv Clinics in February 2022?
In February 2022, Aviv Clinics highlighted a study demonstrating that Hyperbaric Oxygen Therapy can improve symptoms and brain structure in veterans suffering from treatment-resistant PTSD.

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcareDigital Therapeutics
Technologies
Artificial IntelligencePlatforms & InterfacesMobile
Target customers
Healthcare & Life SciencesHealthcareProvidersPatientsConsumersDemographics & FamilySeniors
Business model
B2B

Highlights

1 PatentsVerified

Tags

digital-healthcaremedical-datanutritionclinicsmobile-applicationsdata-scienceactionable-insightstherapeuticsdigital-therapeuticshome-carepreventionpersonalizationbig-data-analyticsseniorswearableartificial-intelligenceaging-populationwearable